Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice (Q38724102)

5 September 2017

Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice (English)

1 reference

5 September 2017

hepatocellular carcinoma

1 reference

Guojun Hou

1

1 reference

5 September 2017

Lei Chen

2

1 reference

5 September 2017

Gang Liu

3

1 reference

5 September 2017

Liang Li

4

1 reference

5 September 2017

Yuan Yang

5

1 reference

5 September 2017

He-Xin Yan

6

1 reference

5 September 2017

Hui-Lu Zhang

7

1 reference

5 September 2017

Jing Tang

8

1 reference

5 September 2017

Ying Cheng Yang

9

1 reference

5 September 2017

Ximeng Lin

10

1 reference

5 September 2017

Xin Chen

11

1 reference

5 September 2017

Gui Juan Luo

12

1 reference

5 September 2017

Yanjing Zhu

13

1 reference

5 September 2017

Shanhua Tang

14

1 reference

5 September 2017

Jin Zhang

15

1 reference

5 September 2017

Hui Liu

16

1 reference

5 September 2017

Qingyang Gu

17

1 reference

5 September 2017

Ling-Hao Zhao

18

1 reference

5 September 2017

Yixue Li

19

1 reference

5 September 2017

Lei Liu

20

1 reference

5 September 2017

Weiping Zhou

21

1 reference

5 September 2017

Hongyang Wang

22

1 reference

5 September 2017

language of work or name

English

0 references

publication date

27 December 2016

1 reference

5 September 2017

1 reference

5 September 2017

65

1 reference

5 September 2017

5

1 reference

5 September 2017

1628-1644

1 reference

Cancer statistics in China, 2015.

5 September 2017

1 reference

Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting

21 January 2018

1 reference

Global cancer statistics, 2012

21 January 2018

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma

21 January 2018

1 reference

Prognostic molecular markers in hepatocellular carcinoma: a systematic review

21 January 2018

1 reference

Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling

21 January 2018

1 reference

Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics

21 January 2018

1 reference

Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinoma

21 January 2018

1 reference

Targeting aldehyde dehydrogenase 2: new therapeutic opportunities

21 January 2018

1 reference

Genetic and environmental influences on ethanol consumption: perspectives from preclinical research

21 January 2018

1 reference

ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications

21 January 2018

1 reference

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

21 January 2018

1 reference

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

21 January 2018

1 reference

MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients

21 January 2018

1 reference

Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4.

21 January 2018

1 reference

Acetyl-coenzyme A carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients

21 January 2018

1 reference

ALDH2(E487K) mutation increases protein turnover and promotes murine hepatocarcinogenesis

21 January 2018

1 reference

Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate

21 January 2018

1 reference

ALDH-2 deficiency increases cardiovascular oxidative stress--evidence for indirect antioxidative properties

21 January 2018

1 reference

Matrix metalloproteinases and tumor metastasis

21 January 2018

1 reference

A redox-dependent mechanism for regulation of AMPK activation by Thioredoxin1 during energy starvation.

21 January 2018

1 reference

Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma

21 January 2018

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk

21 January 2018

1 reference

Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals

21 January 2018

1 reference

Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin.

21 January 2018

1 reference

AMPK: positive and negative regulation, and its role in whole-body energy homeostasis

21 January 2018

1 reference

The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?

21 January 2018

1 reference

The LKB1-AMPK pathway: metabolism and growth control in tumour suppression

21 January 2018

1 reference

Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma

21 January 2018

1 reference

The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

21 January 2018

1 reference

AMPK, the metabolic syndrome and cancer

21 January 2018

1 reference

Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications

21 January 2018

1 reference

7 January 2021

Potential diagnostic and prognostic marker dimethylglycine dehydrogenase (DMGDH) suppresses hepatocellular carcinoma metastasis in vitro and in vivo

1 reference

7 January 2021

A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma

1 reference

7 January 2021

Patient understanding of genetic principles and their expectations of genetic services within the NHS: a qualitative study

1 reference

7 January 2021

Heterotetramers of human liver mitochondrial (class 2) aldehyde dehydrogenase expressed in Escherichia coli. A model to study the heterotetramers expected to be found in Oriental people

1 reference

7 January 2021

Genetic polymorphisms of ALDH2 and ADH2 are not associated with risk of hepatocellular carcinoma among East Asians

1 reference

7 January 2021

Regulation of hepatic metabolism by AMPK

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.29006

1 reference

5 September 2017

1 reference